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To help understand the mechanism of pathogenesis of dengue virus (DV), we set out to create an infectious cDNA of the Brazilian prototype
strain of DV serotype 1 (DV1-BR/90). PCR-amplified fragments of DV1-BR/90 cDNA were readily assembled into a subgenomic cDNA that
could be used to produce replicating RNAs (replicons), lacking the structural protein-encoding regions of the genome. However, assembly of a
cDNA capable of producing infectious virus was only possible using a bacterial artificial chromosome plasmid, indicating that DV1 sequences
were especially difficult to propagate in E. coli. While characterizing our cDNAwe discovered a fortuitous temperature-sensitive mutation in the
NS1 encoding region. Using our infectious cDNA and a renilla luciferase-expressing replicon we were able to demonstrate that this mutation
produced a defect in RNA replication at 37 °C, demonstrating that the DV1 NS1 protein plays an essential role in RNA replication.
© 2006 Elsevier Inc. All rights reserved.Keywords: Dengue virus; Replicon; NS1; Temperature-sensitive mutant; ReplicationIntroduction
Dengue viruses (DV) are the etiologic agents of dengue fever
(DF), dengue hemorrhagic fever and dengue shock syndrome.
The viruses are transmitted to humans by Aedes mosquitoes.
DV infections are a serious cause of morbidity and mortality in
most tropical and subtropical areas of the world. Dengue cases
are estimated to occur in up to 100 million individuals annually.
DV belongs to the Flavivirus genus in the family Flaviviridae
and there are four serotypes (DV1 to 4) (Burke and Monath,
2001). The four serotypes of DV do not confer cross-protective
immunity, and epidemiological evidence indicates that immu-
nity to one serotype of DV increases the chance of more severe⁎ Corresponding author. Department of Pathology, University of Texas
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doi:10.1016/j.virol.2006.11.026diseases upon infection with a second serotype by about ten-
fold (Kurane and Ennis, 1997).
Flaviviruses are single-stranded, positive-sense RNAviruses
that have an approximately 11-kb genome consisting of a single
open reading frame encoding three structural proteins (C, preM/
M and E) and seven non-structural proteins (NS1, NS2A,
NS2B, NS3, NS4A, NS4B and NS5), with non-translated
regions at its 5′ and 3′ terminal (5′UTR and 3′UTR). Flavivirus
RNA replication occurs in the cytoplasm via a negative-strand
intermediate, leading to the accumulation of positive-strand
RNAs. Several NS proteins have been implicated in the process.
The NS2B/NS3 serine proteinase is required for processing at
multiple sites in the NS polyprotein. NS3 also possesses RNA
triphosphatase and RNA helicase activities. NS5 contains
methyltransferases and RNA-dependent RNA polymerase
(Lindenbach and Rice, 2001).
NS1 is a highly conserved glycoprotein containing 12
invariant C residues and two potential N-linked glycosylation
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elucidated, several lines of evidence suggest that NS1 is
involved in viral RNA replication (Lindenbach and Rice, 1997;
Mackenzie et al., 1996; Muylaert et al., 1997; Westaway et al.,
1997).
Infectious clones have been obtained for multiple flavi-
viruses. The first systems, developed for yellow fever virus
{YFV (Rice et al., 1989)} and DV4 (Lai et al., 1991), overcame
the genetic instability of flaviviral genomes in standard E. coli
plasmids by propagating the 5′ and 3′ halves of the genomes
into separate fragments, followed by in vitro ligation of the
fragments to produce a template for production of synthetic
genome-length RNAs. Subsequent strategies that have been
used to propagate genome-length cDNAs that could be used
directly as templates for the production of infectious RNAs have
included the use of yeast plasmids (Polo et al., 1997), low-copy
plasmids (Gualano et al., 1998) or bacterial artificial chromo-
somes (BAC) plasmids (Van der Most et al., 1999) to overcome
these E. coli instability problems.
Based on our successful strategy of using low-copy plasmids
to propagate cDNAs for flavivirus replicons that were readily
converted into genome-length clones for West Nile virus
(WNV) (Rossi et al., 2005) and Japanese encephalitis virus
(JEV) (Ishikawa, Konishi and Mason, unpublished), we
designed a similar strategy to produce an infectious cDNA for
DV1. Although our low-copy plasmid was suitable for DV1
replicon construction, we were unable to use this plasmid to
produce an infectious genome-length DV1 cDNA. However, anFig. 1. (A) Schematic representation of the DV1-BR/90 genome showing the position
andMluI) and fragments used to assemble the replicon cDNA encoded by pACDV1r
the SapI and the HDV-RZ/bacteriophage T7 terminator fragments (which included a d
the right. (B) Schematic representation of the structural protein-encoding cDNA fra
pBACDV1flcNS1*NS3*. (C) Structure and position of Rluc encoding cistron added
the position of coding differences with the BR/90 amplicon (see Table 1 and text foinfectious cDNA was readily obtained in a BAC plasmid.
Furthermore, while characterizing this cDNA we discovered a
fortuitous mutation in NS1 that produced a temperature-
sensitive (ts) form of the protein that permitted us to
demonstrate the importance of NS1 in DV genome replication.
Results
Construction of cDNA encoding a replicon and an infectious
DV1 RNA
Standard methods were used to create a subgenomic replicon
from DV1-BR/90, the prototype strain of DV1 isolated in 1990
from a DF patient in Rio de Janeiro, Brazil. The viral RNAwas
extracted from infected C6/36 cells, reverse transcribed into
cDNA and amplified in individual dsDNA fragments as shown
in Fig. 1. The five individual fragments required to produce a
replicon-length cDNA were readily assembled into the low-
copy plasmid pACDV1poly. Synthetic RNAs produced from
this plasmid (designated pACDV1repNS1*NS3*; see below)
replicated well when introduced into BHK cells (see Fig. S1).
Comparison of the sequence of this replicon and the PCR
amplicons used to generate it revealed two changes in encoded
amino acids, one in NS1 and a second in NS3 (see Table 1,
discussed in detail below). Nevertheless, cells transfected with
this replicon produced high levels of antigen when detected
with either a polyclonal sera (results not shown) or a MAb to
NS1 (Fig. S1).of the restriction enzymes sites (NotI, BspTI, NgoMIV, PshAI, PmlI, SapI, XhoI
epNS1*NS3*. Position of the T7 promoter is shown on the left, and positions of
ownstream SwaI site for linearization and an XhoI site for insertion) are shown at
gment present in pACDV1T7-C-NS1 and the cDNA present in BAC plasmid
to the 3′ UTR of DV1repNS1*. The “*” above NS1 and NS3 are used to indicate
r details).
Table 1
Summary of nucleotide and amino acid sequence a differences between the GenBank-deposited sequences of BR/90, the BR/90 amplicons used to generate our
infectious cDNAs and various cloned cDNAs
Base position
(codon) b
Coding
region
BR/90
GenBank c
BR/90
amplicons
pACDV1rep
NS1*NS3*
pACDV1
T7-C-NS1
pBACDV1flc
NS1*NS3*
pBACDV1flc
325 C A G G G G
1213 E A U U U U
1258 E U C C C C
1291 E U C C C C
1378 E A G G G G
1639 E C U U U U
1648 E U C C C C
2719 NS1 G A A A A
3159 (247) NS1 A (Y) d A (Y) d G (C) G (C) A (Y) d
3265 NS1 C U U U U
3346 NS1 U U C C U
3424 NS1 C U U U U
3907 (144) NS2A C (H) G (Q) d G (Q) d G (Q) d G (Q) d
4627 NS3 G A A A A
5250 (211) NS3 A (Q) d A (Q) d G (R) G (R) A (Q) d
5413 NS3 A A A A G
6148 NS3 U U C C C
6598 NS4A A A G G G
10,195 NS5 G G A A A
10,258 NS5 A A G G G
a Encoded amino acid sequences, when different, are shown in “()”.
b Position of nucleotide change (within genome) and codon change (within the individual protein-encoding region).
c AF226685.
d Amino acid encoded at this position in all GenBank-deposited DV1 sequences examined (AY145121, AB178040, NC_001477, AY732483, AY726555,
DQ193572, AB204803, AF311956, AF311957, AF311958, and AF513110) except for AF226685 (see text).
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pACDV1repNS1*NS3*, we created a low-copy plasmid
encoding the 5′UTR and C-NS1 polyprotein of DV1-BR/90
(designated pACDV1T7-C-NS1; Fig. 1). Sequence analyses of
pACDV1T7-C-NS1 confirmed that its sequence was identical
to that in the DV1-BR/90 amplicons used to create it. Using
multiple different restriction endonuclease assembly strategies,
genome-length cDNAs were very difficult to assemble from
pACDV1repNS1*NS3* and pACDV1T7-C-NS1. Furthermore,
even when obtained, bacterial colonies harboring plasmids that
had restriction maps consistent with full-length cDNAs grew
very poorly. Moreover, when RNAs produced from the cDNA
templates prepared from these bacteria were transfected into
BHK cells, they failed to produce cells expressing any
detectable DV1 antigen (results not shown). Since we
successfully applied these same assembly methods to recover
infectious cDNAs for WNV (Rossi et al., 2005) and JEV
(Ishikawa, Konishi, and Mason, unpublished), these results
suggested an especially severe genetic incompatibility/instabil-
ity of full-length DV1 cDNAs in E. coli (see Introduction).
To overcome the apparent genetic instability/incompatibil-
ity of the DV1 cDNA sequences with our low-copy plasmid,
we transferred the subgenomic replicon cDNA to a BAC
plasmid and then added back the 5′ end of the genome en-
coding the structural proteins from pACDV1T7-C-NS1 (see
Fig. 1). Initial analyses demonstrated that synthetic RNAs from
all three full-length BAC plasmid clones isolated from the first
assembly attempt produced large numbers of antigen-positive
cells (Fig. S2). One of these BAC plasmids, designatedpBACDV1flcNS1*NS3*, was sequenced in its entirety (see
Table 1) and used for all further studies.
Characterization of DV1flcNS1*NS3*
BHK cells transfected with synthetic RNA produced from
pBACDV1flcNS1*NS3* produced large numbers of antigen-
positive cells when stained with antibodies specific for either E
or NS1 (up to 50% of the cells in these cultures were antigen-
positive 2 days after electroporation). However, the number of
immunopositive cells in these cultures did not increase upon
further cultivation, and infectious titer of DV in the supernatant
fluid recovered from cells at all days up to and including day
8 post-electroporation was undetectable (Fig. S2 and results not
shown). When C7/10 cells were electroporated with this RNA
transcribed from this cDNA, a small number of immunopositive
cells were detected on day 2, indicating that our electroporation
methods were less efficient with mosquito cells than with BHK
cells. However, by day 4, most of the cells in these transfected
cultures were immunopositive, and by day 6, all cells stained
strongly with DV-specific antibodies (Fig. 2). These results
suggest that DV1 infection spread in these C7/10 cells,
furthermore, titration of the supernatant fluid recovered from
these electroporated cells revealed viral replication (approxi-
mately 4×103 focus-forming units (ffu)/ml on day 5 when
titrated on C7/10 cells), indicating that pBACDV1flcNS1*NS3*
was an infectious cDNA. However, the foci size of this virus,
designated DV1flcNS1*NS3*, appeared smaller than parental
DV1-BR/90 on C7/10, C6/36 and especially Vero cells (Fig. S3.
Fig. 2. Micrograph of monolayers of C7/10 cells electroporated with the in vitro
transcript of pBACDV1flcNS1*NS3* and then fixed at the indicated time post-
electroporation and stained with MAb D2-7E11.
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To begin to dissect the reason of phenotypic difference bet-
ween DV1flcNS1*NS3* and DV1-BR/90, a detailed comparison
was made between the entire cDNA in pBACDV1flcNS1*NS3*,
the RNA stock used to create it and various DV1 sequences
(summarized in Table 1). These analyses confirmed that the
assembly of the genomic fragments from the low-copy plas-
mids pACDV1repNS1*NS3* and pACDV1T7-C-NS1 into
pBACDV1flcNS1*NS3* did not result in the selection of any
nucleic acid differences, confirming the utility of the BAC
plasmid in propagating the DV1 cDNAs. These analyses also
confirmed that there were only 3 coding differences between the
GenBank-deposited sequence of BR/90 (AF226685) and
pBACDV1flcNS1*NS3*. Although a number of sequence diffe-
rences appeared to be restricted to particular cloned fragments, it
is unclear if the differences obtained in the E. coli-propagated
cDNA fragments represented quasispecies in the viral RNA or a
combination of PCR-introduced errors and E. coli selection
(Table 1 and results not shown).
In the case of the three coding mutations, the NS2A position
#144 difference between the GenBank-deposited sequence for
DV1-BR/90 and our PCR amplicon was discounted from consi-
deration since the Q encoded by our parental virus PCR
amplicon and all of our cloned cDNAs (Fig. 1, Table 1 and results
not shown) was shared bymultiple other GenBank sequences for
DV1 (see Table 1). The NS1 Yat position 247 and the NS3 Q at
aa position 211 were present in our BR/90 amplicon, and all
GenBank-deposited DV1 sequences examined (see above, and
Table 1), but were altered in pBACDV1flcNS1*NS3*, and the
low-copy plasmid-propagated cDNAs used to create it (Table 1).
Furthermore, sequencing of several other low-copy plasmid
clones of DV1-BR/90 cDNA spanning these regions demon-
strated that it was possible to clone cDNA plasmids with the
consensus sequence contained in the parental viral cDNA
amplicon (results not shown), thus these two differences wereconsidered mutations associated with PCR amplification and/or
cloning in low-copy plasmids.
To examine the role of the NS1 and NS3 mutations on the
DV1flcNS1*NS3* phenotype, several additional infectious
cDNAs were engineered with wild-type (WT) codons at one or
both of these positions (Fig. 3). The infectivity of these full-length
DV1 transcripts was tested in BHK and C7/10 cells. Cells were
transfected with RNA transcripts by using Lipofectin and cultured
for 4 days under a semi-solid overlay followed by immunostaining
for DV1 antigen as shown in Fig. 3B. When RNAs were
transfected into C7/10 cells, foci formation was observed in all
clones, however, foci produced by RNAs obtained from
pBACDV1flcNS1*NS3* and pBACDV1flNS3* were smaller
than the foci produced from the cDNA plasmids encoding the WT
NS3Q, indicating that the Rmutation in NS3 resulted in small foci
size in C7/10 cells. In the case of transfected BHK cells, RNAs
derived from clones with the WT NS1 sequences
(pBACDV1flcNS3* and pBACDV1flc) produced foci (Fig. 3B),
whereas RNAs from pBACDV1flcNS1*NS3* did not produce
foci, and very small foci were observed with RNAs produced from
pBACDV1flcNS1* (Fig. 3B). These results suggest that, although
mutations in either NS1 or NS3 affected viral production in BHK
cells, the NS1 mutation was the primary cause of defect of DV1
growth in these cells. As expected, side-by-side plaque assays of
DV1flc and the parental virus on C7/10 cells and Vero cells
showed indistinguishable plaque morphologies (Fig. 3C).
Phenotypic characterization of NS1 mutant
To further investigate the effect of the NS1 mutation on viral
production from our infectious cDNAs, we compared the
production of virus from cells infected with WT and NS1 mutant
viruses at 30 °C or 37 °C. To this end, BHK cells were
electroporated with transcribed RNA from pBACDV1flcNS1* or
pBACDV1flc, diluted with naive BHK cells, and following
attachment, the cell monolayers were cultured for 5 days under a
semi-solid overlay and then immunostained to reveal DV1 foci. As
shown in Fig. 4, foci morphology was similar for the progeny
viruses derived from both pBACDV1flcNS1* or pBACDV1flc
RNAs in BHK cells at 30 °C. However, in contrast, foci produced
by RNA from pBACDV1flcNS1* were smaller than those
produced by RNA from pBACDV1flc when these viruses were
propagated in the cells at 37 °C (Fig. 4). To further explore the
effect of temperature on the replication of DV1flcNS1*, side-by-
side growth curves were generated with this virus and DV1flc in
infected Vero cells grown at 30 °C and 37 °C (Fig. 5). These
studies showed that at 30 °C, DV1flcNS1* replicated at similar
levels to DV1flc. However, at 37 °C, DV1flcNS1* growth was
delayed relative to DV1flc. Taken together, these results indicate
that a C at codon 247 in NS1 produces a ts defect in NS1.
Effect of NS1 mutation on virus entry
Since NS1 is retained in the same cellular compartment as
immature flavivirus provirions (Lindenbach and Rice, 2001),
we reasoned that mutation 247 in NS1 could alter virus
maturation and/or NS1 could be associated with the virion,
Fig. 3. Demonstration of the effect of NS1 and NS3 mutations on recombinant
virus focus formation on monolayers of C7/10 and BHK cells. (A) Schematic
representation of the genome of DV1 showing all of the amino acid coding
differences between DV1-BR/90 and our BAC plasmid encoded genomes. The
position of amino acid residues of NS1 and NS3 that differed between these
genomes is shown at the top; bold type has been used to designate the amino
acids of consensus sequence in DV1 (see text and Table 1). (B) Photographs of
monolayers C7/10 and BHK cells transfected with Lipofectin using similar
amounts of synthetic RNA (20 ng) from the indicated BAC clones, overlaid with
semi-solid media and stained with anti-NS1 antibody 4 days after transfection.
(C) Photographs of monolayers C7/10 and Vero infected with DV1-BR/90 or
DV1flc, overlaid with semi-solid media and fixed and immunostained with anti-
NS1 antibody 4 days (C/710) or 5 days (Vero) after incubation at 30 °C (C7/10)
or 37 °C (Vero).
Fig. 4. Photographs of monolayers of cells transfected with synthetic RNA from
pBACDV1flcNS1* and pBACDV1flc and then grown at 30 °C or 37 °C. BHK
cells were electroporated with transcribed RNA from pBACDV1flcNS1* and
pBACDV1flc, diluted with naive BHK cells, incubated for 5 days at indicated
temperature then fixed and stained with MAb D2-7E11. In all cases, the same
dilution (10-fold) of electroporated cells is shown.
Fig. 5. Growth curves of DV1flcNS1* and DV1flc on Vero cells at 30 °C or
37 °C. Monolayers of Vero cells were infected with the indicated virus at a
multiplicity of infection (MOI) of 0.01 and incubated at the indicated
temperature. At each time point, the media were removed and frozen for
subsequent titration and fresh media were added. Virus titers in cell culture
medium were determined by plaque assay in Vero cells incubated at 30 °C.
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mutation altered virion maturation and/or its infectivity at the
non-permissive temperature, we performed a temperature shift
experiment. In this assay, WT and mutant virus were incubated
with Vero cells at 30 °C or 37 °C for 5 h (long enough to bind,penetrate and uncoat the genome of DV) and then incubated for
5 days at either of these temperatures. The results of this
experiment, shown in Fig. 6, demonstrate that the NS1 mutation
does not affect virus binding or establishment of replication
since the WT and mutant viruses produce similar numbers of
foci and similar-sized foci if the infection is conducted at 30 °C
or 37 °C and then followed by a 5-day incubation at 30 °C.
However, the number and size of foci produced by DV1flcNS1*
were both drastically reduced when the post-entry phase of the
experiment was performed at 37 °C (Fig. 6). These results
suggest that this NS1 mutation has little (or no) effect on virus
entry and uncoating and is likely to effect RNA genome
replication and/or packaging and virion release.
Effect of NS1 ts mutation on RNA replication
To evaluate the role of the NS1 mutation in RNA replication,
we developed a replicon of DV1 containing the renilla
Fig. 6. Effect of temperature shift on infectious foci formation by cells infected
with same numbers of ffu of DV1flcNS1* and DV1flc. The left side of the figure
shows the incubation temperatures utilized for the 5-h attachment/infection and
5-day growth/spread portion (performed under semi-solid overlay) of the
experiment, and the right side of the figure shows the resulting monolayers,
fixed and stained with MAb D2-7E11 to reveal infectious foci (see Materials and
methods).
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NS1 mutation (see Materials and methods and Fig. 1). These
replicon RNAs were electroporated into BHK cells, and
luciferase activities were measured at 6 h and 4 days post-
electroporation. The values obtained 6 h after electroporation
were nearly identical for both replicons at both temperatures,
indicating that as expected the differences in NS1 position 247
had no effect on the initial translational activity of the reporter
gene encoded by the transfected replicon RNA. For the later time
point, these 6-h activities were used to normalize for transfection
efficiency (see legend for Fig. 7). These Rluc data show that theFig. 7. Effect of NS1 mutation on DV1 RNA replication. BHK cells were
electroporated with identical amount of Rluc-expressing DV1 subgenomic
replicon RNAs (with or without the NS1 position 247 mutation), seeded in
multi-well plates, and incubated at 30 °C or 37 °C prior to harvesting lysates for
the determination of Rluc activity (see Materials and methods). Rluc activities
were measured at 6 h and 4 days post-electroporation. The Rluc activity obtained
at 4 days is shown normalized to the activity obtained at 6 h to account for slight
differences in transfection efficiency (see text). Data from each condition are
shown as an average of triplicate values with error bars showing standard
deviations.replicon harboring the NS1 mutation (DV1repNS1*) replicated
much more poorly than the WT replicon at 37 °C (Fig. 7). In
contrast, Rluc activities detected in lysates obtained from the
same electroporations and then incubated at 30 °C contained
indistinguishable levels of Rluc activity. These data indicate that
the ts NS1 mutation reduces viral replication by reducing RNA
replication.
Effect of NS1 mutation on polyprotein processing and NS1
secretion
To examine whether the ts mutation in NS1 affected
processing and secretion of NS1 in infected cells, cells were
infected with DV1flcNS1* or DV1flc for 5 days at 30 °C and
then incubated for an additional 2 days at 37 °C. As shown in
Fig. 8A, Western blot analyses revealed no obvious difference
in the electrophoretic migration of NS1* versus NS1 or the
amount of NS1 and NS1* present in cells at this time point.
Furthermore, Western blot analyses of the NS1 present in
the culture fluid harvested from these cells failed to reveal any
gross defect in the dimerization or release of NS1* or NS1 from
these cultures (Fig. 8B). Specifically, a heat-labile NS1 form
matching the predicted dimer MWof 90 k was present in culture
fluid harvested from cells infected with either DV1flcNS1* or
DV1flc. Despite the lack of detectable differences in the quality
of NS1 produced by DV1flcNS1* or DV1flc in cells grown at
the non-permissive temperature for DV1flcNS1*, we did note a
slight reduction in NS1* production from cells infected with the
mutant virus, likely the result of the reduction in RNA repli-
cation detected with this virus when grown at this temperature
(see above, and Fig. 7). Since the ts mutation consisted of theFig. 8. Affect of NS1 mutation on NS1 synthesis and secretion. Western blots
prepared from samples of cell lysates and supernatant fluids obtained from Vero
cells infected at an MOI of 0.01 ffu with either DV1flcNS1* and DV1flc viruses
(or mock-infected), incubated for 5 days at 30 °C (to allow both viruses to infect
the entire monolayer) and then shifted to 37 °C for 2 days. The media were
changed three times with serum free medium 1 day before harvest to insure that
the NS1 protein analyzed represented protein produced at the final incubation
temperature. (A) Replica of Western blot showing the NS1 protein (detected
with MAb D2-7E11) present in cell lysates. (B) Replica of Western showing the
NS1 protein released from the indicated cell monolayers at 37 °C, following
electrophoresis after denaturation in the presence or absence (to preserve dimers)
of heating, and detection with MAb D2-7E11.
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bond formation in NS1*, we compared the electrophoretic
migration of non-reduced forms of NS1 and NS1* in lysates of
cells prepared at the non-permissive temperature. These
analyses failed to reveal any altered migration (specifically
aggregation, associated with improper disulfide formation;
(Lorenz et al., 2002); results not shown) suggesting that the ts
mutation was not exerting its influence on RNA replication
through a gross alteration in NS1 structure or intracellular
localization.
Discussion
Infectious cDNAs have been reported for a large number of
flaviviruses, including most of the important human pathogens.
In some cases, the apparent incompatibility of full-length viral
cDNAs with commonly used E. coli recombinant DNA
propagation systems has hampered development of these
important reagents. Here we have demonstrated the utility of
a BAC plasmid system for propagation of a highly infectious
cDNA from a South American strain of DV1. Specifically, the
cDNAs propagated in BAC plasmids could be used as template
for RNA transcription that generated highly infectious RNAs
with a specific infectivity of more than 104 ffu/μg of RNA.
BAC plasmids have been used by others to produce infectious
cDNA clones for YFV (Van der Most et al., 1999), JEV (Yun et
al., 2003) and DV2 (Pierro et al., 2006), but these investigators
did not directly compare BAC plasmids to low-copy plasmids,
which have been recently employed by several investigators to
produce full-length clones of flaviviruses (see Introduction). In
our hands, precisely the same low-copy plasmid methods that
were used to successfully establish replicons and infectious
cDNAs for WNV (Rossi et al., 2005) and JEV (Ishikawa,
Konishi and Mason, unpublished) were successfully used to
produce infectious DV1 replicons, but these methods were not
able to be used to produce infectious full-length DV1 genomes.
It is not clear the reason for the differences between these
flaviviruses, but one possibility is that DV1 cDNAs or
spontaneously produced translation products are more toxic to
E. coli cells than the products produced from other flavivirus
cDNAs.
The strain selected for our studies, DV1-BR/90, is a well-
characterized South American prototype strain derived from an
isolate obtained early after the introduction of DV1 to Brazil.
We selected this strain due to the availability of animal-adapted
derivatives (Duarte dos Santos et al., 2000) and the fact that
DV1-BR/90 provides a useful starting point for comparisons to
strains of DV1 that have evolved in Brazil since the introduction
of DV1 to South America (Duarte dos Santos et al., 2002).
Thus, this cDNA will be useful for understanding the
involvement of animal-adapted and naturally evolved mutations
in DV1 replication, transmission and pathogenesis.
The DV NS1 protein contains two N-linked glycosylation
sites and 12 conserved C residues that have been shown to form
6 disulfides (Wallis et al., 2004). NS1 is secreted from
mammalian, but not mosquito cells (Mason, 1989) and exists
as a heat-labile homodimer (Winkler et al., 1988). Alteration ofselected C residues, or the N residues that are glycosylated
during NS1 processing, results in the loss of dimerization and
secretion of the NS1 protein, suggesting that dimerization is
necessary for NS1 secretion (Pryor and Wright, 1993).
However, cells infected with a Kunjin virus with a defect in
NS1 dimer formation were able to secrete NS1, and the virus
could replicate, suggesting that dimerization of NS1 is not an
absolute requirement for NS1 secretion as well as NS1 function
(Hall et al., 1999). Although a specific function of extracellular
forms NS1 has not yet been demonstrated, NS1 has been shown
to be important for replication of YFV. Specifically, mutations
at the first or both N-linked glycosylation sites of YFV NS1 led
to dramatic defects in RNA replication and virus production
(Muylaert et al., 1996). Furthermore, a single amino acid
substitution at position 299 in the YFV NS1 protein resulted in a
defective for RNA accumulation and delayed viral production
in a ts manner (Muylaert et al., 1997). Finally, trans-
complementation studies revealed that NS1 has an important
function at a very early stage in RNA replication (Lindenbach
and Rice, 1997).
Our ts NS1 mutant virus, DV1flcNS1*, encodes an
additional C residue between the naturally occurring C residues
number 6 and 7. At the permissive temperature (30 °C), this
virus is indistinguishable from the WT virus (DV1flc) in terms
of growth and infectious focus formation. In addition,
DV1flcNS1* appears to infect and uncoat with equal efficiency
as theWT virus. However, DV1flcNS1* is retarded with respect
to virion production at 37 °C. By using a subgenomic replicon
encoding an Rluc reporter gene, we were able to demonstrate
that the ts defect due to the additional C residue was manifest at
the level of reduced RNA replication.
Examination of the processing of NS1* at the non-
permissive temperature showed no obvious differences relative
to WT NS1. Since the alteration in NS1* resulted in the
substitution of an extra C residue for a Y residue, we
specifically tested to see if this alteration was associated with
changes in dimerization, secretion or misfolding, which could
accompany the addition of an unnatural C, resulting in impaired
disulfide bond formation. However, we were unable to detect
any difference in synthesis, secretion or dimerization of NS1*
when the ts mutant virus was grown at the non-permissive
temperature (37 °C). These results suggest that the Y residue at
position 247 in NS1, which is highly conserved in all DV1
examined (Table 1), might be important for function of NS1.
Interestingly, a P to L substitution at residue 250 in Kunjin virus
NS1 also produced a mutant virus with delayed replication (Hall
et al., 1999), and an R to A mutation at residue 299 in YFV NS1
was also responsible for a ts RNA synthesis phenotype
(Muylaert et al., 1997), indicating that this C-terminal region
of NS1 plays a critical role in RNA replication for multiple
flaviviruses.
The NS1* mutation resulted in a significant delay in virus
production at the non-permissive temperature during first 5 days
of DV1flcNS1* infection in Vero cells, consistent with a role for
NS1 in the early phases of viral RNA replication. However,
DV1flcNS1* titers were indistinguishable from DV1flc titers at
9 days post-infection, suggesting that later stages of virus
381R. Suzuki et al. / Virology 362 (2007) 374–383replication were less affected by this mutation. Interestingly, the
ts mutation in NS1* appeared to be relatively stable since we
were unable to detect revertants following attempts to grow the
virus at 37 °C.
The mutation that we detected in DV1flcNS1* reduces virus
yield at 37 °C, suggesting that it could attenuate viremia in vivo,
a property that is correlated with disease severity in man
(Murgue et al., 2000; Vaughn et al., 2000). Thus, our NS1*
mutation (or alternative mutations in the C-terminal region of
NS1) might be a useful additions to live-attenuated vaccine
candidates for dengue.
In summary, our work on an infectious cDNA system for
DV1 has demonstrated the advantage of the BAC plasmid over
a widely utilized low-copy plasmid and has identified a novel ts
mutation in NS1 that has been used to demonstrate a role for
NS1 in DV RNA synthesis.
Materials and methods
Plasmids, viruses and cell lines
A low-copy plasmid, designated pACDV1poly, was derived
from pACNR (Ruggli et al., 1996) by adding a custom
polylinker containing NotI, BspTI, BspEI, NgoMIV, PshAI,
PmlI and XhoI restriction endonuclease sites to facilitate
cloning of DV1 cDNA fragments. A BAC plasmid designated
pBACDV1poly was derived from pBeloBAC11 (a BAC
plasmid containing the Ori2 origin of replication and F (fertility)
factor of E. coli (Shizuya et al., 1992); obtained from I. Frolov)
by removal of a non-essential NotI fragment and substitution of
a directional polylinker containing a NotI, BamHI, XhoI and
SwaI restriction endonuclease sites to facilitate directional
insertion of DV1 cDNAs fragments cloned into low-copy
plasmids.
DV1-BR/90, a Brazilian DV1 strain isolated from an adult
male with DF in Rio de Janeiro, RJ, Brazil, in 1990 has been
previously described (Despres et al., 1993; Nogueira et al.,
1993). This isolate was obtained from P. Despres (Interactions
Moleculaires Flavivirus-Hôtes, Institut Pasteur, 25 rue du Dr.
Roux, 75724, Paris, cedex 15, France) and then was passaged
an additional 4 times in C6/36 cells, prior to use. Virus stocks
were maintained at −80 °C.
BHK cells were maintained at 37 °C in minimal essential
medium (MEM—Invitrogen) supplemented with 10% fetal
bovine serum (FBS—Gemini) and antibiotics. Vero cells were
maintained at 37 °C in MEM containing 6% FBS and
antibiotics. C7/10 and C6/36 mosquito cell lines were
maintained at 30 °C in Leibovitz's L15 medium (Invitrogen)
supplemented with 10% FBS, 10% tryptose phosphate broth
(Sigma) and antibiotics.
cDNA synthesis, amplification and cloning
Total cellular RNA was extracted from BR/90-infected C6/
36 cells using RNAqueous (Ambion). DV1 RNA present in this
preparation was reverse-transcribed using random hex oligo-
nucleotide primers and Improm-II reverse transcriptase (Pro-mega). Fragments of DV1-BR/90 cDNAwere amplified by the
polymerase chain reaction (PCR) using specific oligonucleotide
primers (see Fig. 1) and a high-fidelity Taq polymerase (Sigma).
The resulting double-stranded cDNA fragments were resolved
by gel electrophoresis, purified by standard methods (Qiagen),
digested with restriction endonucleases and cloned into
pACDV1poly (see Fig. 1). The oligonucleotide used to amplify
the 5′UTR included a T7 promoter recognition site and an
additional G preceding the first base of the viral genome. In
addition, a synthetic antisense oligonucleotide was used to add a
BspTI site at codons 30–31 of the C-coding region (following
the cyclization sequence), and a sense oligonucleotide was
designed that added the same site preceding the final
transmembrane domain of the E protein coding sequence to
permit the ligation of C to NS1, permitting the construction of a
subgenomic replicon (Fig. 1). Finally, two alternative strategies
were designed to create synthetic run-off transcripts that
contained a 3′ terminus identical to the viral RNA. The first
consisted the introduction of a type IIS restriction endonuclease
site (SapI) downstream of the 3′ end of the cDNA by using an
antisense oligo containing an XhoI site and the SapI site fused
to the complement of the 3′ end of the DV1 genome
(CCGCTCGAGGCTCTTCGAGAACCTGTTGATTCAA-
CAGC). The second strategy consisted of using oligonucleo-
tides to fuse a hepatitis delta virus ribozyme (HDV-RZ)/
bacteriophage T7 terminator fragment (Mason et al., 2002) to
the 3′ end of the cDNA using an overlap PCR construction
strategy (Higuchi et al., 1988). PCR-generated cDNA fragments
were individually inserted into pACDV1poly (in some cases by
a multiple step-wise addition process recreating the natural
junctions) and the resulting molecularly cloned plasmids were
isolated by standard techniques and sequences were checked by
automatic nucleotide sequencing and compared to the sequence
of PCR amplicons obtained from mosquito cells infected with
DV1-BR/90 and the original DV1-BR/90 sequence deposited
with GenBank (AF226685). Fragments were assembled into
genome-length cDNAs in the pACDV1poly and pBACDV1-
poly by standard methods (see Fig. 1).
To construct subgenomic DV1 replicons expressing a
humanized Rluc reporter, overlap PCR (Higuchi et al., 1988)
was used to fuse an EMCV IRES to a humanized Rluc gene
derived from pGL4.73 (Promega), and this cassette was inserted
into the variable region of the 3′-UTR (in place of bases −447 to
−279 from the last base in the DV1 genome in pBACDV1rep
and related plasmids (see Fig. 1)).
RNA synthesis using in vitro transcription reactions
Plasmids were purified by centrifugation in CsCl gradients
using standard methods. Plasmids were prepared for run-off
transcription by digestion with SapI restriction endonucleases
or SwaI (in the case of HDV-RZ-encoding plasmids), and the
resulting template DNAs were in vitro transcribed using
MegaScript T7 synthesis kit (Ambion) supplemented with a
7mG(ppp)G cap analogue (NEB). This 7mG(ppG) cap
analogue was added to permit efficient capping of this synthetic
transcript, which was designed to encode an unnatural G in front
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synthesis with phage T7 polymerase (which produces much
higher levels of RNA from transcripts beginning with a G). The
yield and integrity of transcripts were analyzed by gel
electrophoresis under nondenaturing condition, and aliquots
of transcription reactions were used for transfection without
additional purification.
RNA transfection
RNA was transfected into BHK or C7/10 monolayers using
Lipofectin (Invitrogen) by a slight modification of the
manufacturer's suggested protocol. Three hours after transfec-
tion, the RNA/Lipofectin/media was removed from the cell
layer and the cells were re-fed with growth media and incubated
at 30 or 37 °C, as required. BHK or C7/10 cells were
electroporated with T7 transcription reactions as previously
described (Rossi et al., 2005).
Detection of DV-antigen in transfected cells by
immunohistochemical staining
DV1 antigen expressing cells were labeled by a modification
of previously described methods (Rossi et al., 2005). Briefly,
cell monolayers were rinsed with PBS, fixed in cold acetone/
methanol (1:1), air-dried, rehydrated with PBS containing 1%
normal horse serum (NHS; Sigma) and incubated with DV-
specific antibodies (polyclonal hyperimmune murine ascitic
fluid (HIMAF) from DV1-infected mice (supplied by R.B.
Tesh), an E-specific monoclonal antibody (MAb) D1-4G2
(Gentry et al., 1982) (supplied by R.B. Tesh) or the NS1-
specific MAb D2-7E11 (Mason et al., 1990) (provided by J.R.
Putnak, WRAIIR, Washington DC)) followed by a peroxidase-
conjugated anti-mouse secondary antibody (KPL), and perox-
idase-labeled cells were stained with the VIP substrate (Vector
Laboratories).
Western blot analysis
Proteins present in cell culture fluid or obtained from triton-
lysed monolayers (lysed in 0.1% triton X-100, 300 mM NaCl,
50 mM Tris, pH 7.6) of infected cells were resolved by SDS-
PAGE (NuPAGE; Invitrogen) and then electrophoretically
transferred to polyvinylidene difluoride membranes (Immobi-
lon). After blocking, these membranes were probed with MAb
D2-7E11 (anti-NS1) and then washed and incubated with a
peroxidase-conjugated anti-mouse antibody (KPL). The deco-
rated NS1 proteins were then detected with the ECL Plus
Western Blotting Detection System (GE Healthcare) and the
image was captured on X-ray film.
Viral titrations and growth curves
Cell monolayers prepared in multi-well plates were incubat-
ed with dilutions of virus and then overlaid with growth media
(in some cases containing 0.8% carboxymethyl cellulose
(CMC; Sigma, medium viscosity)) and incubated for theindicated times and then fixed and immunostained as described
above, and foci were counted and used to calculate a titer of ffu/
ml. For growth curves, Vero cells were infected and then
incubated at the indicated temperature and at selected intervals
the media was removed for storage at −80 °C (for subsequent
titration) and replaced with fresh media.
Renilla luciferase assay
Monolayers of BHK cells electroporated with Rluc-expres-
sing plasmids were lysed by addition of Reporter Lysis Buffer
(Promega), and the lysates were stored at −20 °C for
subsequent assay. Prior to assay, the extracts were thawed
and clarified to remove insoluble debris, and a portion of each
extract was mixed with 5 volumes of an Rluc reaction buffer
(100 mM EDTA, 50 mM Tris, pH 8.0, containing 5 μg/ml
Coelenterazine; Nanolight technology) in black-walled 96-well
microtitration plates. Following a 1 min incubation period,
luminescence was determined using a Microplate Luminometer
(Applied Biosystems).
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